Literature DB >> 22318674

Restoration of dystrophin expression using the Sleeping Beauty transposon.

Sofia Muses1, Jennifer E Morgan, Dominic J Wells.   

Abstract

The Sleeping beauty (SB) system is a non-viral DNA based vector that has been used to stably integrate therapeutic genes into disease models. Here we report the SB system is capable of stably integrating the ΔR4-R23/CTΔ micro-dystrophin gene into a conditionally immortal dystrophin deficient muscle cell-line, H2K SF1, a murine cell model for Duchenne muscular dystrophy. Genetically corrected H2K SF1 cells retained their myogenic properties in vitro. Moreover, upon transplantation ΔR4-R23/CTΔ micro-dystrophin expression was detected within mdx nu/nu mice. Our data suggests the SB system is an effective way of stably integrating therapeutic genes into myogenic cells.

Entities:  

Year:  2011        PMID: 22318674      PMCID: PMC3269885.1          DOI: 10.1371/currents.RRN1296

Source DB:  PubMed          Journal:  PLoS Curr        ISSN: 2157-3999


  37 in total

1.  RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues.

Authors:  Andrew Wilber; Joel L Frandsen; Jennifer L Geurts; David A Largaespada; Perry B Hackett; R Scott McIvor
Journal:  Mol Ther       Date:  2005-12-20       Impact factor: 11.454

Review 2.  Nonviral vectors for gene delivery.

Authors:  Meredith A Mintzer; Eric E Simanek
Journal:  Chem Rev       Date:  2009-02       Impact factor: 60.622

3.  Sleeping beauty transposition from nonintegrating lentivirus.

Authors:  Conrad A Vink; H Bobby Gaspar; Richard Gabriel; Manfred Schmidt; R Scott McIvor; Adrian J Thrasher; Waseem Qasim
Journal:  Mol Ther       Date:  2009-05-05       Impact factor: 11.454

4.  Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transfer.

Authors:  Helen Foster; Paul S Sharp; Takis Athanasopoulos; Capucine Trollet; Ian R Graham; Keith Foster; Dominic J Wells; George Dickson
Journal:  Mol Ther       Date:  2008-09-02       Impact factor: 11.454

5.  Systemic correction of storage disease in MPS I NOD/SCID mice using the sleeping beauty transposon system.

Authors:  Elena L Aronovich; Jason B Bell; Shaukat A Khan; Lalitha R Belur; Roland Gunther; Brenda Koniar; Patricia A Schachern; Josh B Parker; Cathy S Carlson; Chester B Whitley; R Scott McIvor; Pankaj Gupta; Perry B Hackett
Journal:  Mol Ther       Date:  2009-04-21       Impact factor: 11.454

Review 6.  Combining stem cells and exon skipping strategy to treat muscular dystrophy.

Authors:  Mirella Meregalli; Andrea Farini; Yvan Torrente
Journal:  Expert Opin Biol Ther       Date:  2008-08       Impact factor: 4.388

7.  Messenger RNA as a source of transposase for sleeping beauty transposon-mediated correction of hereditary tyrosinemia type I.

Authors:  Andrew Wilber; Kirk J Wangensteen; Yixin Chen; Lijuan Zhuo; Joel L Frandsen; Jason B Bell; Zongyu J Chen; Stephen C Ekker; R Scott McIvor; Xin Wang
Journal:  Mol Ther       Date:  2007-04-17       Impact factor: 11.454

8.  Hybrid lentivirus-transposon vectors with a random integration profile in human cells.

Authors:  Nicklas H Staunstrup; Brian Moldt; Lajos Mátés; Palle Villesen; Maria Jakobsen; Zoltán Ivics; Zsuzsanna Izsvák; Jacob Giehm Mikkelsen
Journal:  Mol Ther       Date:  2009-02-24       Impact factor: 11.454

9.  Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates.

Authors:  Lajos Mátés; Marinee K L Chuah; Eyayu Belay; Boris Jerchow; Namitha Manoj; Abel Acosta-Sanchez; Dawid P Grzela; Andrea Schmitt; Katja Becker; Janka Matrai; Ling Ma; Ermira Samara-Kuko; Conny Gysemans; Diana Pryputniewicz; Csaba Miskey; Bradley Fletcher; Thierry VandenDriessche; Zoltán Ivics; Zsuzsanna Izsvák
Journal:  Nat Genet       Date:  2009-05-03       Impact factor: 38.330

10.  Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells.

Authors:  Arianna Dellavalle; Maurilio Sampaolesi; Rossana Tonlorenzi; Enrico Tagliafico; Benedetto Sacchetti; Laura Perani; Anna Innocenzi; Beatriz G Galvez; Graziella Messina; Roberta Morosetti; Sheng Li; Marzia Belicchi; Giuseppe Peretti; Jeffrey S Chamberlain; Woodring E Wright; Yvan Torrente; Stefano Ferrari; Paolo Bianco; Giulio Cossu
Journal:  Nat Cell Biol       Date:  2007-02-11       Impact factor: 28.824

View more
  3 in total

1.  Autologous Cell Therapy Approach for Duchenne Muscular Dystrophy using PiggyBac Transposons and Mesoangioblasts.

Authors:  Pavithra S Iyer; Lionel O Mavoungou; Flavio Ronzoni; Joanna Zemla; Emanuel Schmid-Siegert; Stefania Antonini; Laurence A Neff; Olivier M Dorchies; Marisa Jaconi; Malgorzata Lekka; Graziella Messina; Nicolas Mermod
Journal:  Mol Ther       Date:  2018-02-02       Impact factor: 11.454

2.  piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts.

Authors:  Mariana Loperfido; Susan Jarmin; Sumitava Dastidar; Mario Di Matteo; Ilaria Perini; Marc Moore; Nisha Nair; Ermira Samara-Kuko; Takis Athanasopoulos; Francesco Saverio Tedesco; George Dickson; Maurilio Sampaolesi; Thierry VandenDriessche; Marinee K Chuah
Journal:  Nucleic Acids Res       Date:  2015-12-17       Impact factor: 16.971

3.  Peptide-Functionalized Dendrimer Nanocarriers for Targeted Microdystrophin Gene Delivery.

Authors:  Jessica Hersh; José Manuel Condor Capcha; Camila Iansen Irion; Guerline Lambert; Mauricio Noguera; Mohit Singh; Avinash Kaur; Emre Dikici; Joaquín J Jiménez; Lina A Shehadeh; Sylvia Daunert; Sapna K Deo
Journal:  Pharmaceutics       Date:  2021-12-15       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.